Fierce Biotech Fundraising Tracker '26: Celea raises $180M for phase 3 study of PureTech IPF drug

Fuente: FierceBiotech
The Fierce Biotech Fundraising Tracker records venture capital rounds of $50 million or more secured by biotechs.
Volver